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Materials and methods: A total of 246 unrelated patients with MI (27-69
years old) and 230 healthy controls (35-69 years old) were included in this study.
The MspI polymorphism of the p53 gene was evaluated by PCR-RFLP method.
Results: The genotype distribution for the MspI variant of the p53 gene in
MI patients (M1M1: n=115, 46.7%; M1M2: n=122, 49.6%; M2M2: n=9,
3.7%) and controls (M1M1: n = 134, 58.3%; M1M2: n = 92, 40.0%; M2M2:
n=4, 1.7%) was significantly different (p = 0.029). Similarly, the allelic fre-
quency was also different (p = 0.017). The odds ratio for MI related to the M2
allele was 1.43 (95% CI=1.05 – 1.95).
Conclusion: These results suggest that the MspI polymorphism of the p53
gene is associated with MI in Tunisian population. 
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Introduction: Paraoxonase 2 (PON2) has antioxidant properties similar to
paraoxonase-1 and paraoxonase-3. However, in contrast to paraoxonase-1 and
paraoxonase-3, paraoxonase-2 is not associated with high-density lipoproteins
and may only exert its antioxidant function at the cellular level. PON2 may
also play a role in the pathogenesis of arterial thrombosis and atherosclerosis.
The purpose of the present study was to investigate the possible association
between the Cys311Ser polymorphism of PON2 gene and myocardial infarc-
tion (MI) in the Tunisian male population
Materials and methods: A total of 700 unrelated Tunisian subjects
including 321 patients with MI and 379 healthy controls were included in this
study. Genomic DNA was extracted from peripheral blood leukocytes
according to standard methods. PON2 genotypes were determined by PCR-
RFLP method.
Results: A significant difference in genotype distribution and allele fre-
quencies was observed between MI patients and controls. Patients with MI
had a frequency of 17.1% for CC genotype, 45.8% for the CS genotype and
37.1% for the SS genotype. The controls had a frequency of 26.1% for the CC
genotype, 45.6% for the CS genotype and 28.2% for the SS genotype
(χ²=10.58; p=0.005). The MI patient group showed a significantly higher fre-
quency of the S allele compared to the controls (0.60 vs 0.51; χ² =11.16;
p<0.001). In multivariate analysis, C311S polymorphism was independently
associated with MI (p<0.001).
Conclusion: Our results showed a significant and independent association
between the PON2 C311S polymorphism (presence of S allele) and MI in the
Tunisian male population. 
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